Development of a Murine FcgRIV-Specific Antibody-Dependent Cell-mediated Cytotoxicity ADCC Reporter Assay
Part # PS224
Teresa Surowy, Aileen Paguio and Frank Fan
R&D, Promega Corporation, 2800 Woods Hollow Road, Madison WI 53711, USA.
We describe here our development of a bioluminescent murine FcgRIV-specific ADCC reporter assay. ADCC pathway activation by target cell-bound antibodies is achieved via FcgRIV-mediated NFAT activation and consequent induction of reporter luciferase activity in dual engineered Jurkat effector cells. We have further developed the assay with thaw-and-use effector cells for immediate use, reducing assay variability and providing convenience.
Printed in USA.